Movement Disorders Pharm Flashcards
Levadopa/Carbidopa (Sinemet)
Known as “Gold standard of treatment”
May be useful to treat dysphasia, seilorrhea, seborrhea and improve functional ability and other secondary motor symptoms.
Most effective against rigidity and slowness.
Less benefit for tremor, balance and gait.
Wearing off effect
May occur within 4-6 years of treatment
Initially may be bradykinesia or tremor in am before next dose.
on/off
add COMT inhibitor to prevent
Levadopa/Carbidopa (Sinemet) CI
Concurrent use with MAOI’s
Psychotic patients
Angle-closure glaucoma
Hx of melanoma
Precautions:
Cardiac disease
PUD
MAO-B Inhibitors: Selegiline (Eldepryl, Zelapar)
Stops the breakdown of dopamine
Enhances peak levadopa levels (use in combo, not alone) Rasagiline (Azilect)
NEUROPROTECTIVE properties by reducing oxidative metabolism of dopamine
Lipophilic and penetrates blood-brain barrier rapidly
MAO-B Inhibitors CI
Concurrent use with TCA’s, SSRI’s and Demerol (Psychiatric disorders)
Dopamine Agonists:
Pramipexole (Mirapex) and Ropirinole (Requip)
Stimulate dopamine receptors in the substantia nigra
Effective in delaying motor complications during the first years of treatment
Studies also report improvement in impaired movements and disability.
Dopamine Agonists: Apomorphine (Apokyn)
To treat acute episodes of “hypermobility” or “freezing”
Given SQ
Very expensive
Cause profound nausea, must be given with antiemetic
COMT Inhibitors: Entacapone (Comtan), Tolcapone (Tasmar)
Increases concentration of existing dopamine in the brain by inhibiting its breakdown.
Only indicated in patients taking levadopa/carbidopa
Diminishes peripheral metabolism of Levodopa
*check LFT’s
Amantadine Adverse Effects:
Sedation Vivid dreams Dry mouth Depression Hallucinations
Caution with renal dysfunction*
Anticholinergic Acetylcholine-blocking Drugs CI
BPH
Obstructive GI disease
Angle closure glaucoma